Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nugenix is a leading consumer health brand specializing in men's vitality and performance supplements, most notably recognized for its testosterone-boosting formulations. Originally developed by Direct Digital (now Adaptive Health), the brand focuses on utilizing clinically researched ingredients like Testofen to address age-related declines in male health. Its product portfolio includes solutions for free testosterone support, prostate health, sexual wellness, and multivitamins. Nugenix operates primarily in the nutraceutical space, distributing products through major retailers like GNC and direct-to-consumer channels. The brand is currently a subsidiary of Adaptive Health, which was acquired by The Bountiful Company and subsequently became part of Nestlé Health Science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nugenix.